Franklin Resources’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-684,482
| Closed | -$27.2M | – | 3225 |
|
|
2026
Q1 | $27.2M | Sell |
684,482
-1,683,899
| -71% | -$43.1M | 0.01% | 865 |
|
|
2025
Q4 | $59.2M | Sell |
2,368,381
-190,033
| -7% | -$4.81M | 0.01% | 592 |
|
|
2025
Q3 | $62M | Buy |
2,558,414
+14,875
| +0.6% | +$264K | 0.02% | 566 |
|
|
2025
Q2 | $33.4M | Buy |
2,543,539
+1,540
| +0.1% | +$19.5K | 0.01% | 758 |
|
|
2025
Q1 | $36.6M | Buy |
2,541,999
+233,453
| +10% | +$3.82M | 0.01% | 711 |
|
|
2024
Q4 | $38.7M | Buy |
2,308,546
+6,000
| +0.3% | +$99.4K | 0.01% | 696 |
|
|
2024
Q3 | $38.4M | Buy |
2,302,546
+1,145,823
| +99% | +$14M | 0.01% | 685 |
|
|
2024
Q2 | $10.4M | Hold |
1,156,723
| – | – | ﹤0.01% | 1063 |
|
|
2024
Q1 | $13.1M | Buy |
1,156,723
+40,906
| +4% | +$387K | ﹤0.01% | 993 |
|
|
2023
Q4 | $8.88M | Buy |
1,115,817
+283,469
| +34% | +$1.9M | ﹤0.01% | 962 |
|
|
2023
Q3 | $5.39M | Hold |
832,348
| – | – | ﹤0.01% | 1070 |
|
|
2023
Q2 | $5.15M | Hold |
832,348
| – | – | ﹤0.01% | 1107 |
|
|
2023
Q1 | $3.2M | Hold |
832,348
| – | – | ﹤0.01% | 1231 |
|
|
2022
Q4 | $2.58M | Sell |
832,348
-584
| -0.1% | -$2.17K | ﹤0.01% | 1303 |
|
|
2022
Q3 | $3.35M | Hold |
832,932
| – | – | ﹤0.01% | 1191 |
|
|
2022
Q2 | $4.06M | Buy |
832,932
+216,029
| +35% | +$1.38M | ﹤0.01% | 1158 |
|
|
2022
Q1 | $5.53M | Buy |
616,903
+41,365
| +7% | +$377K | ﹤0.01% | 1144 |
|
|
2021
Q4 | $6.48M | Sell |
575,538
-346,562
| -38% | -$4.66M | ﹤0.01% | 1163 |
|
|
2021
Q3 | $15.4M | Sell |
922,100
-600
| -0.1% | -$12.4K | 0.01% | 954 |
|
|
2021
Q2 | $20.5M | Buy |
+922,700
| New | +$21.7M | 0.01% | 850 |
|
Franklin Resources's CNTA Position: Q2 2026 in Review
Franklin Resources sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 684,482 shares — an estimated $27.2M sold.
Franklin Resources first reported a position in CNTA in Q2 2021 and held it in 20 quarters. The position peaked at $62M in Q3 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.
- Franklin Resources reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Franklin Resources sold 684,482 Centessa Pharmaceuticals shares in Q2 2026, an estimated $27.2M.
- Franklin Resources first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 20 quarters.
- Franklin Resources's Centessa Pharmaceuticals position peaked at $62M in Q3 2025.
- 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.